Safety and efficacy during first line with cetuximab in KRAS wild-type metastatic colorectal cancer (mCRC): Results of a large prospective multicenter cohort carried out by the premium French observational study.
Laurent Mineur
No relevant relationships to disclose
Gilles Seni
No relevant relationships to disclose
Laurent Miglianico
No relevant relationships to disclose
louis-Marie Dourthe
No relevant relationships to disclose
Nathalie Bonichon
No relevant relationships to disclose
Lionel Moreau
No relevant relationships to disclose
Rosine Guimbaud
No relevant relationships to disclose
Denis Smith
No relevant relationships to disclose
Emmanuel Achille
No relevant relationships to disclose
Robert Herve
No relevant relationships to disclose
Jean Michel Bons
No relevant relationships to disclose
Stephane Remy
No relevant relationships to disclose
jean Pierre Daures
No relevant relationships to disclose